Drug intelligence / Profile preview

Amolin

Development stage: Unknown
Lead developer: Bayer
Modality: Drug Delivery Systems
Administration: Topical, Oral

Overview

Amolin is primarily an oil-rich cream formulated for babies' sensitive skin, used to treat and prevent nappy rash. It soothes sore or chafed skin and is applied lightly and gently after each nappy change. It is for external use only. There may also be a version of Amolin that is an amoxicillin antibiotic product in some regions.

Brand names: Amolin

Beyond the preview

Go deeper on Amolin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amolin.

Explore the full profile